Association of a CCB-Related Pharmacogenomics-Guided Strategy with Blood Pressure Outcomes and Short-Term Safety in Chinese Patients with Hypertension: A Secondary Exploratory Analysis of Two Randomized Cohorts. [PDF]
Drug Healthc Patient SafDeng K +8 more
europepmc +1 more source
Prescription patterns of sacubitril/valsartan among patients with hypertension in Japan. [PDF]
Front Cardiovasc MedOzaki AF +6 more
europepmc +1 more source
Efficacy and Safety of a Single-Pill Triple Combination of Valsartan, Amlodipine, and Chlorthalidone in Patients With Essential Hypertension Inadequately Controlled on Dual Therapy With Valsartan and Amlodipine: A Randomized, Double-Blind, Multicenter, Phase 3 Trial. [PDF]
J Clin Hypertens (Greenwich)Cho IJ +10 more
europepmc +1 more source
Correction to: Should Incretin Agonist-Based Drugs be Considered for First Line Antihypertensive Therapy? [PDF]
Curr Hypertens RepKylies D, Dreher L, Wenzel UO.
europepmc +1 more source
The longitudinal care cascade for hypertension in people with and without HIV in South Africa: A clinic-based observational study. [PDF]
PLoS MedGumede SB +5 more
europepmc +1 more source
A mechanistic study on the enhanced antihypertensive effects of a <i>Dendrobium officinale</i> compound combined with Western antihypertensive drugs in spontaneously hypertensive rats based on metabolomics and gut microbiota analysis. [PDF]
Front Cell Dev BiolWu R +11 more
europepmc +1 more source
Zilebesiran, a Small Interfering RNA Therapeutic Targeting Angiotensinogen: Mechanism, Clinical Evidence, Safety, and Implementation Considerations. [PDF]
Life (Basel)Jawaria +5 more
europepmc +1 more source
Impact of the national centralized volume-based procurement policy on antihypertensive drug procurement, price, and volume in Guangxi: an interrupted time series analysis of procurement data. [PDF]
Front PharmacolLiang S +5 more
europepmc +1 more source